Physician profile
Robert T Ferguson
NPI 1619186897
$21,946.21
in general payments reported to CMS, 2019-2025
19 companies · $630 in 2025
The $630 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $27.40 · 2021: $243 · 2022: $4,755 · 2023: $548 · 2024: $806 · 2025: $630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,663 · Travel and Lodging: $278 · Gift: $43.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,662.57 |
| Travel and Lodging | $278.46 |
| Gift | $43.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $19,183.93 | 2019-2024 | Da Vinci Sp, Da Vinci Surgical System |
| Veran Medical Technologies, INC. | $1,328.30 | 2019 | |
| Medical Device Business Services, INC. | $296.17 | 2024-2025 | Echelon Flex, Echelon Endopath |
| Kls-Martin L.P. | $209.84 | 2021-2025 | |
| Pulmonx Corporation | $158.99 | 2025 | Zephyr Delivery Catheter, Chartis Catheter, Zephyr Endobronchial Valve |
| Astrazeneca Pharmaceuticals LP | $131.44 | 2023 | Imfinzi |
| Medtronic, INC. | $125.88 | 2021 | |
| Galvanize Therapeutics, INC | $81.14 | 2025 | Aliya System |
| Atricure, INC. | $76.78 | 2024 | |
| Covidien LP | $51.26 | 2019-2020 | |
| Pfizer INC. | $50.32 | 2023 | |
| Medtronic Vascular, INC. | $47.44 | 2019 | |
| Lexington Medical, INC. | $46.32 | 2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Bard Access Systems, INC. | $41.96 | 2019 | |
| Abiomed | $35.87 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $25.63 | 2024 | |
| Ethicon US, LLC | $20.24 | 2025 | Echelon; Endopath, Endopath Xcel |
| Inspire Medical Systems, INC. | $18.12 | 2023 | Inspire |
| Baxter Healthcare | $16.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.